Immune reconstitution: From stem cells to lymphocytes

Gay M. Crooks, Kenneth Weinberg, Crystal Mackall

Research output: Contribution to journalArticle

Abstract

Although the problem of immune reconstitution after HSCT has been addressed indirectly by supportive care measures, new knowledge of the biology of transplantation should allow us to move forward in directly attacking the problem. Strategies to improve the development of T lymphocytes via thymic-dependent pathways involve the generation, isolation, and manipulation of prethymic cells, including CLPs. Understanding of the reciprocal relationships between lymphoid progenitors and the thymic microenvironment have allowed small-animal model testing of either IL-7 replacement or FGF-mediated protection and regeneration of TECs. The elucidation of the TCR and cytokine requirements for the thymus-independent homeostatic cycling and peripheral expansion of mature T cells is leading to studies of either enhancement of immune responses to antigens or to improved survival and efficacy of adoptively transferred T lymphocytes. Although all of these approaches have solid preclinical supporting data, a major challenge to the HSCT community will be the implementation of clinical trials that will allow proper evaluation of their safety, efficacy, and best use.

Original languageEnglish (US)
Pages (from-to)42-46
Number of pages5
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Volume12
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Stem Cells
Lymphocytes
T-Lymphocytes
Interleukin-7
Histocompatibility Antigens Class II
Thymus Gland
Regeneration
Animal Models
Transplantation
Clinical Trials
Cytokines
Safety

ASJC Scopus subject areas

  • Transplantation

Cite this

Immune reconstitution : From stem cells to lymphocytes. / Crooks, Gay M.; Weinberg, Kenneth; Mackall, Crystal.

In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Vol. 12, No. SUPPL. 1, 01.2006, p. 42-46.

Research output: Contribution to journalArticle

@article{f879a439949a4262b1025fa1483e6af8,
title = "Immune reconstitution: From stem cells to lymphocytes",
abstract = "Although the problem of immune reconstitution after HSCT has been addressed indirectly by supportive care measures, new knowledge of the biology of transplantation should allow us to move forward in directly attacking the problem. Strategies to improve the development of T lymphocytes via thymic-dependent pathways involve the generation, isolation, and manipulation of prethymic cells, including CLPs. Understanding of the reciprocal relationships between lymphoid progenitors and the thymic microenvironment have allowed small-animal model testing of either IL-7 replacement or FGF-mediated protection and regeneration of TECs. The elucidation of the TCR and cytokine requirements for the thymus-independent homeostatic cycling and peripheral expansion of mature T cells is leading to studies of either enhancement of immune responses to antigens or to improved survival and efficacy of adoptively transferred T lymphocytes. Although all of these approaches have solid preclinical supporting data, a major challenge to the HSCT community will be the implementation of clinical trials that will allow proper evaluation of their safety, efficacy, and best use.",
author = "Crooks, {Gay M.} and Kenneth Weinberg and Crystal Mackall",
year = "2006",
month = "1",
doi = "10.1016/j.bbmt.2005.10.015",
language = "English (US)",
volume = "12",
pages = "42--46",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Immune reconstitution

T2 - From stem cells to lymphocytes

AU - Crooks, Gay M.

AU - Weinberg, Kenneth

AU - Mackall, Crystal

PY - 2006/1

Y1 - 2006/1

N2 - Although the problem of immune reconstitution after HSCT has been addressed indirectly by supportive care measures, new knowledge of the biology of transplantation should allow us to move forward in directly attacking the problem. Strategies to improve the development of T lymphocytes via thymic-dependent pathways involve the generation, isolation, and manipulation of prethymic cells, including CLPs. Understanding of the reciprocal relationships between lymphoid progenitors and the thymic microenvironment have allowed small-animal model testing of either IL-7 replacement or FGF-mediated protection and regeneration of TECs. The elucidation of the TCR and cytokine requirements for the thymus-independent homeostatic cycling and peripheral expansion of mature T cells is leading to studies of either enhancement of immune responses to antigens or to improved survival and efficacy of adoptively transferred T lymphocytes. Although all of these approaches have solid preclinical supporting data, a major challenge to the HSCT community will be the implementation of clinical trials that will allow proper evaluation of their safety, efficacy, and best use.

AB - Although the problem of immune reconstitution after HSCT has been addressed indirectly by supportive care measures, new knowledge of the biology of transplantation should allow us to move forward in directly attacking the problem. Strategies to improve the development of T lymphocytes via thymic-dependent pathways involve the generation, isolation, and manipulation of prethymic cells, including CLPs. Understanding of the reciprocal relationships between lymphoid progenitors and the thymic microenvironment have allowed small-animal model testing of either IL-7 replacement or FGF-mediated protection and regeneration of TECs. The elucidation of the TCR and cytokine requirements for the thymus-independent homeostatic cycling and peripheral expansion of mature T cells is leading to studies of either enhancement of immune responses to antigens or to improved survival and efficacy of adoptively transferred T lymphocytes. Although all of these approaches have solid preclinical supporting data, a major challenge to the HSCT community will be the implementation of clinical trials that will allow proper evaluation of their safety, efficacy, and best use.

UR - http://www.scopus.com/inward/record.url?scp=29844457858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29844457858&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2005.10.015

DO - 10.1016/j.bbmt.2005.10.015

M3 - Article

C2 - 16399583

AN - SCOPUS:29844457858

VL - 12

SP - 42

EP - 46

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - SUPPL. 1

ER -